In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity.
Although the relevance of the present study to the human disease deserves further investigation, these findings may be useful to future studies using this model of colitis aimed to understand the pathophysiology of IBD
A study published in Frontiers in Endocrinology advised that, since both oral and injectable semaglutide are effective, the choice between them should be based on individual preferences, convenience and specific health needs, ensuring the treatment best aligns with the patients lifestyle
Here we have investigated the role of the mtGSH transporter SLC25A40 in macrophage activation
At Revolution Health & Wellness, we specialize in cutting-edge therapies, including peptide treatments, to address chronic gastrointestinal inflammation and dysfunction
Fat loss and weight management